PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
News|Articles|December 15, 2016
IPEC-Americas Announces New Executive Committee Members
Author(s)Pharmaceutical Technology Editors
IPEC-Americas held elections for executive committee positions at the annual board of trustee’s dinner.
Advertisement
IPEC-Americas hosted their annual board of trustee’s dinner meeting on Dec. 7, 2016 in Arlington, VA. During the meeting the board received reports on IPEC-Americas 2016 accomplishments and ongoing council activities from Priscilla Zawislak, chair.
The group also held elections. Because a quorum was not present, elections took place via email and in person at the meeting. In addition to elections, a proposed 2017 budget was approved. The following are the results for the Executive Committee positions:
Chair Elect
Janeen Skutnik-Wilkinson, Compliance & Standards, Biogen
Vice Chair for Administrative Affairs
Bretta Lichtenhan, Regulatory Surveillance and Advocacy, Global Regulatory Management, MilliporeSigma
Vice Chair Harmonization and Compendial Monograph
Phyllis Walsh, associate director, Merck & Company, Inc.
Elected Executive Committee Members
George Collins Jr., vice-president, Vanderbilt Mineral Co.
Heather Sturtevant, manager, Technical Operations, Johnson & Johnson Consumer Inc.
Meera Raghuram, manager, Regulatory Affairs & Strategies, Lubrizol Advanced Materials, Inc.
Source: IPEC-Americas
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement